Table 4.
Unadjusted and adjusted odds ratios for all-cause and clinically related 30-day hospital readmissions between intervention (Phase 1 and 2) and usual care groups.
| Groups | OR | 95% CI | p | aOR | 95% CI | p |
|---|---|---|---|---|---|---|
| All-cause 30-day hospital readmissions | ||||||
| Phase 1 * | 1.97 | 0.88–4.43 | 0.10 | 1.20 | 0.49–2.95 | 0.69 |
| Phase 2 * | 1.52 | 0.49–4.70 | 0.47 | 0.78 | 0.21–2.89 | 0.71 |
| Phase 2 ^ | 0.77 | 0.26–2.27 | 0.64 | 0.99 | 0.30–3.37 | 0.99 |
| Phase 1 | Ref. | - | - | Ref. | - | - |
| Clinically-related 30-day hospital readmissions | ||||||
| Phase 1 * | 3.75 | 0.99–14.2 | 0.052 | 2.87 | 0.69–11.9 | 0.15 |
| Phase 2 * | 4.65 | 0.99–21.8 | 0.051 | 4.11 | 0.52–32.3 | 0.18 |
| Phase 2 ^ | 1.24 | 0.36–4.30 | 0.73 | 1.46 | 0.37–5.76 | 0.59 |
| Phase 1 ^ | Ref. | - | - | Ref. | - | - |
Abbreviations: CI, confidence interval; OR, odds ratio; aOR, adjusted odds ratio. * Represents odds in each phase compared to odds in the control group. Adjusted models controlled for age, gender, race, LACE index, and number of medications ordered at hospital discharge. ^ Represents the odds in Phase 2 compared with the odds in Phase 1. Adjusted models controlled for age, gender, race, LACE index, number of medications ordered at hospital discharge, and time until completion of TOC intervention.